PCL Inc
PCL, Inc. provides multiplex in vitro diagnostic (IVD) products and platform services. The company offers HiSU solution, an automated multi-immune diagnostic system that performs various diagnostics, high-speed tests including blood screening, multiple cancer screening, autoimmune testing, etc. It also provides antigen and antibody diagnostic kits, including PCLOK II anti-HIV/HCV/syphilis, and PC… Read more
PCL Inc (241820) - Total Liabilities
Latest total liabilities as of December 2024: ₩14.46 Billion KRW
Based on the latest financial reports, PCL Inc (241820) has total liabilities worth ₩14.46 Billion KRW as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
PCL Inc - Total Liabilities Trend (2015–2024)
This chart illustrates how PCL Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
PCL Inc Competitors by Total Liabilities
The table below lists competitors of PCL Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Promateris SA
RO:PPL
|
Romania | RON109.63 Million |
|
Educational Development Corporation
NASDAQ:EDUC
|
USA | $13.56 Million |
|
Wijaya Karya Bangunan Gedung Tbk PT
JK:WEGE
|
Indonesia | Rp2.31 Trillion |
|
Morien Resources Corp
PINK:APMCF
|
USA | $1.41 Million |
|
Tandy Leather Factory Inc
NASDAQ:TLF
|
USA | $31.16 Million |
|
Wulff-Yhtiot Oy
HE:WUF1V
|
Finland | €38.10 Million |
|
Madison Metals Inc.
OTCQB:MMTLF
|
USA | $435.50K |
Liability Composition Analysis (2015–2024)
This chart breaks down PCL Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.67 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PCL Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PCL Inc (2015–2024)
The table below shows the annual total liabilities of PCL Inc from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩14.46 Billion | -41.18% |
| 2023-12-31 | ₩24.58 Billion | -56.40% |
| 2022-12-31 | ₩56.38 Billion | -12.92% |
| 2021-12-31 | ₩64.75 Billion | +850.69% |
| 2020-12-31 | ₩6.81 Billion | -31.37% |
| 2019-12-31 | ₩9.92 Billion | +1029.65% |
| 2018-12-31 | ₩878.46 Million | +100.92% |
| 2017-12-31 | ₩437.22 Million | -69.67% |
| 2016-12-31 | ₩1.44 Billion | -9.28% |
| 2015-12-31 | ₩1.59 Billion | -- |